Atlas Trials

Wang Xin

5 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch Wang Xin

RecordFirmDate
Short-course RT Followed by NALIRIFOX Plus Pucotenlimab as Neoadjuvant Therapy for High-risk Locally Advanced Rectal Cancer With MSS/pMMR (NCT07651007)Wang Xin2026-05-31
PULSAR Combined With Fecal Microbiota Transplantation for Advanced Hepatocellular Carcinoma Progressing After First-Line Targeted-Immunotherapy (NCT07463248)Wang Xin2026-03-05
PULSAR Combined With Immunotherapy and Chemotherapy (NCT07291947)Wang Xin2025-11-04
Prophylaxis of Graft-versus-host Disease With Anti-CD25 Antibody in Patients Underwent HSCT (NCT06334367)Wang Xin2024-03-26
Phase IV Observational Study of Orelabrutinib in the Treatment of Chronic Lymphocytic Leukemia/Small Cell Lymphoma (NCT05920668)Wang Xin2023-07-01

Track Wang Xin automatically

Every clearance here is in the API, with alerts when new ones post.